(Date:11/25/2009)..., BEIJING,Nov.25/PRNewswire-Asia/--SinovacBiotech...announcedtodaythatitexecuted,ajointventure(JV)agre...o.,Ltd.(SinovacDalian).TheJVwillresearch,develop,p...llcontributeitsexpertise,andexperienceindeveloping...tywillbringitslanduserights,manufacturingfacilitie...
(Date:11/25/2009)..., SANDIEGO,Nov.25/PRNewswire-FirstCall/--ArdeaBio...yD.Quart,Pharm.D.,presidentandchiefexecutiveoffice...Conference. , ,Presentationdetailsareasfollows:,...esday,December1,2009,Time:2:00p.m.EasternTime,Loca...ef=,http://www.corporate-ir.net/ireye/,target=,_b...
(Date:11/24/2009)..., HOUSTON,Nov.24/PRNewswire-FirstCall/--IES(Nasda...ommunicationssystemsandservicesforthecommercial,in...scommercialbusinessgrouphasbeenawardedacontractfro...theLevel4bio-safetylab(BSL-4)replacementfacilityat...eases(USAMRIID)atFortDetrickinFrederick,Md. ,, ...
(Date:11/24/2009)... The New York investment bank ...SX:NEU) has agreed an AU$6.7 mil convertible note ...or. The private placement was arranged by KTA Capi...sor. , New York (PRWEB) N...tment bank KTA Capital, LLC ("KTA Capital&quo...
Breaking Biology Technology:Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2.... 13 Allos,Therapeutics, Inc. (Nasdaq: ALTH ), a...ent and commercialization of small molecule therap...d that Paul L. Berns, President and,CEO, will pres...fe Sciences,Conference in New York. The Company,s...n) on,Tuesday, September 25, 2007. There will be a...
.... 13 Abaxis, Inc.,(Nasdaq: ABAX ), a medical pro...alysis systems, announced today that Clint Severso... Company, LLC Sixth Annual San,Francisco Instituti...r 24,2007 at 11:35 a.m. Pacific Time at The Ritz-C...is develops, manufactures and markets portable blo...
...o antisense drugs in development targeting glucago...eptor, - Includes research collaboration to ident...nal targets to treat metabolic diseases - Confer.... EDT at http://www.isisph...ceuticals, Inc. (Nasdaq: ISIS ) today announced a...
Other Biology Technology:Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference 2Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 2Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 3Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 4Isis Enters Broad Collaboration With Ortho-McNeil, Inc. for the Discovery, Development and Commercialization of Antisense Drugs to Treat Metabolic Diseases 5... FAM-Labeled Substrate (green fluorescence; Ex=488...rotease activation • No lysing, fixing, or pe...e cell-permeable, fluorescently labeled inhibitors...sin-like activity in whole living cells. Select fr...
..., known as ChemiArrayTM Mouse Cytokine Antibody Ar...t methodologies. Besides the ability to detect pro...accurate reflection of active cytokine levels beca...plification step is needed. Furthermore, it is sim...
DNA Engine Thermal Cycler Chassis w/384-well block & motorized lid from Bio-Rad
...ay (MSTA) slides were designed to study protein ex...rom multiple species. Tissue slices from three di...ch can then be treated as a single histological sl... situ hybridization. This format allows a rapid ...
Biology Products: